Oral inflammation, a role for antimicrobial peptide modulation of cytokine and chemokine responses

被引:17
作者
Brogden, Kim A. [1 ]
Johnson, Georgia K. [2 ]
Vincent, Steven D. [3 ]
Abbasi, Taher [4 ]
Vali, Shireen [4 ,5 ]
机构
[1] Univ Iowa, Coll Dent, Dow Inst Dent Res, Iowa City, IA 52242 USA
[2] Univ Iowa, Coll Dent, Iowa City, IA 52242 USA
[3] Univ Iowa, Dept Oral Pathol Radiol & Med, Coll Dent, Iowa City, IA 52242 USA
[4] Cellworks Grp Inc, San Jose, CA 95110 USA
[5] Cellworks Res India Pvt Ltd, Bangalore 560066, Karnataka, India
基金
美国国家卫生研究院;
关键词
antimicrobial peptides; chemokines; cytokines; defensins; HBD3; innate immunity; oral inflammation; HUMAN BETA-DEFENSINS; GINGIVAL CREVICULAR FLUID; ENDOTHELIAL GROWTH-FACTOR; PAPILLON-LEFEVRE-SYNDROME; NECROSIS-FACTOR-ALPHA; LICHEN-PLANUS; MUCOSAL LESIONS; PROINFLAMMATORY CYTOKINES; HUMAN BETA-DEFENSIN-3; DIFFERENTIAL EXPRESSION;
D O I
10.1586/14787210.2013.836059
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Acute and chronic inflammation commonly occurs throughout the oral cavity. The most common causes are physical damage and microbial infections, and less frequently immune reactions and malignant changes. All of these processes result in the induction of antimicrobial peptides, chemokines and cytokines that lead to cellular infiltrates, a vascular response, tissue destruction and cellular proliferation. A fascinating concept developing in the current literature suggests that antimicrobial peptides modulate the production of chemokines, cytokines and other cellular mediators and that this may have a larger ramification as an underlying mechanism mediating inflammation. Here, we propose that the ability of antimicrobial peptides to induce chemokines and anti-inflammatory or proinflammatory cytokines plays an important role in the early events of oral inflammation and may be a target for the prevention or treatment of oral inflammatory conditions.
引用
收藏
页码:1097 / 1113
页数:17
相关论文
共 179 条
[1]   Defining the normal bacterial flora of the oral cavity [J].
Aas, JA ;
Paster, BJ ;
Stokes, LN ;
Olsen, I ;
Dewhirst, FE .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (11) :5721-5732
[2]  
Abbasi T, 2012, INNOVATE WHILE DERIS, P9
[3]   Increased expression of Th2-associated chemokines in bullous pemphigoid disease.: Role of eosinophils in the production and release of these chemokines [J].
Abdelilah, Soussi Gounni ;
Wellemans, Vincent ;
Agouli, Mourad ;
Guenounou, Moncef ;
Hamid, Qutayba ;
Beck, Lisa A. ;
Lamkhioued, Bouchaib .
CLINICAL IMMUNOLOGY, 2006, 120 (02) :220-231
[4]   Upregulation of human beta-defensin 2 peptide expression in oral lichen planus, leukoplakia and candidiasis. An immunohistochemical study [J].
Abiko, Y ;
Jinbu, Y ;
Noguchi, T ;
Nishimura, M ;
Kusano, K ;
Amaratunga, P ;
Shibata, T ;
Kaku, T .
PATHOLOGY RESEARCH AND PRACTICE, 2002, 198 (08) :537-542
[5]   Pattern of expression of beta-defensins in oral squamous cell carcinoma [J].
Abiko, Y ;
Mitamura, J ;
Nishimura, M ;
Muramatsu, T ;
Inoue, T ;
Shimono, M ;
Kaku, T .
CANCER LETTERS, 1999, 143 (01) :37-43
[6]   Prevalence of oral lesions among Saudi dental patients [J].
Al-Mobeeriek, Azizah ;
AlDosari, Abdullah M. .
ANNALS OF SAUDI MEDICINE, 2009, 29 (05) :365-368
[7]   Serum levels of IL-4, IL-10, IL-12, IL-13 and IFN-gamma in Behcet's disease [J].
Aridogan, BC ;
Yildirim, M ;
Baysal, V ;
Inaloz, HS ;
Baz, K ;
Kaya, S .
JOURNAL OF DERMATOLOGY, 2003, 30 (08) :602-607
[8]   A Toll-Like Receptor-4-Interacting Surfactant Protein-A-Derived Peptide Suppresses Tumor Necrosis Factor-α Release from Mouse JAWS II Dendritic Cells [J].
Awasthi, Shanjana ;
Brown, Kevin ;
King, Catherine ;
Awasthi, Vibhudutta ;
Bondugula, Rajkumar .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 336 (03) :672-681
[9]  
Banks K, 1998, MT SINAI J MED, V65, P333
[10]   Beta-defensins activate macrophages and synergize in pro-inflammatory cytokine expression induced by TLR ligands [J].
Barabas, Nicola ;
Roehrl, Johann ;
Holler, Ernst ;
Hehlgans, Thomas .
IMMUNOBIOLOGY, 2013, 218 (07) :1005-1011